Expression Profiling of Clear cell renal carcinoma

ABSTRACT: Selecting patients with metastatic clear-cell renal cell carcinoma (m-ccRCC) who might benefit from treatment with targeted tyrosine kinase inhibitors (TKIs) is a challenge. Our aim was to identify molecular markers associated with outcome in m-ccRCC patients treated with sunitinib. A Cartes d’Identite des Tumeurs (CIT) study from the 'Institut Curie' and the french 'Ligue Nationale Contre le Cancer' (http://cit.ligue-cancer.net).

ORGANISM(S): Homo sapiens

SUBMITTER: Elarouci Nabila 

PROVIDER: E-MTAB-3267 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress